Skip to main content

Actuate Therapeutics, Inc.

ACTU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001652935

In the last 90 days, Actuate Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 62 institutions reported holding it in 13F filings for Q2 2026, worth $20.6M in total; no superinvestor holds it.

SEC filings

10-K, 10-Q, 8-K, 20-F and 40-F reports Actuate Therapeutics, Inc. filed with the SEC, newest first.

Livermore lists each filing's form, 8-K items and dates only. To read a filing, open it on SEC.gov; an 8-K's press release or other attachments, such as exhibit 99.1 for Item 2.02, are in the filing index.

SEC filings by Actuate Therapeutics, Inc.
FiledForm8-K itemsPeriodDocumentFiling index
Oct 30, 20268-K3.01Oct 28, 2026SECIndex
Oct 28, 20268-K1.018.019.01Oct 26, 2026SECIndex
Aug 14, 202610-Q–Jun 30, 2026SECIndex
Jul 17, 20268-K3.01Jul 15, 2026SECIndex
May 22, 20268-K5.07May 21, 2026SECIndex
May 14, 202610-Q–Mar 31, 2026SECIndex
May 11, 20268-K7.019.01May 11, 2026SECIndex
May 6, 20268-K5.028.019.01May 1, 2026SECIndex
Mar 26, 202610-K–Dec 31, 2025SECIndex
Jan 12, 20268-K7.019.01Jan 12, 2026SECIndex
Nov 28, 20258-K1.019.01Nov 28, 2025SECIndex
Nov 21, 20258-K8.01Nov 21, 2025SECIndex
Nov 13, 202510-Q–Sep 30, 2025SECIndex
Sep 10, 20258-K1.018.019.01Sep 10, 2025SECIndex
Aug 14, 202510-Q–Jun 30, 2025SECIndex
Jun 26, 20258-K1.013.029.01Jun 25, 2025SECIndex
Jun 5, 20258-K7.019.01May 31, 2025SECIndex
Jun 2, 20258-K7.018.019.01May 31, 2025SECIndex
May 23, 20258-K5.07May 22, 2025SECIndex
May 15, 202510-Q–Mar 31, 2025SECIndex
May 6, 20258-K8.019.01May 6, 2025SECIndex
Mar 28, 20258-K1.013.029.01Mar 27, 2025SECIndex
Mar 13, 202510-K–Dec 31, 2024SECIndex
Feb 7, 20258-K8.01Feb 7, 2025SECIndex
Dec 17, 20248-K7.019.01Dec 17, 2024SECIndex
Nov 13, 202410-Q–Sep 30, 2024SECIndex
Nov 12, 20248-K7.019.01Nov 12, 2024SECIndex
Sep 24, 202410-Q–Jun 30, 2024SECIndex
Aug 19, 20248-K4.019.01Aug 19, 2024SECIndex
Aug 14, 20248-K5.025.038.019.01Aug 14, 2024SECIndex